Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
Clinical trial NCT00544167 · COMPLETED
Trial details
- NCT number
- NCT00544167
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2007-05-01
- Primary completion
- 2008-01-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.